Siteadmin, Check users, nsTeam1RO, nsTeam1RW, nsTeam1_talkRO, nsTeam1_talkRW, oversight, Administrators
30,650
edits
Changes
Jump to navigation
Jump to search
Line 1:
Line 1: − +
Merck recommends it for "girls and women ages 9 to 26" - I say this with a straight face
'''Gardasil''', the recently-available HPV [[vaccine]] intended to prevent infection with the human papillomavirus (HPV). <ref>The vaccine is designed to protect against types 6, 11, 16 and 18 of HPV.</ref>
'''Gardasil''', the recently-available HPV [[vaccine]] intended to prevent infection with the human papillomavirus (HPV) in girls and women ages 9 to 26.<ref>[http://www.gardasil.com/who-should-receive-gardasil.html Who should recieve Gardasil?], Merck official website.</ref> <ref>The vaccine is designed to protect against types 6, 11, 16 and 18 of HPV.</ref>
These strains of HPV are [[sexually transmitted diseases]] endemic among [[promiscuous]] people, with 80% of those who have sex outside of marriage suffering from the disease.<ref>http://www.hopkinsmedicine.org/hnf/hnf_6403.htm</ref> These strains of HPV have been associated with 70% of cervical cancer cases and may also play a role in the development of other types of cancer <ref>[http://www.cancer.gov/cancertopics/factsheet/Risk/HPV]</ref>. In June 2006, the U.S. Food and Drug Administration approved the first HPV vaccine without reviewing any epidemiological studies and merely monitoring for a brief period elevated [[antibody]] levels in recipients of the vaccine.<ref> http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5602a1.htm</ref>
These strains of HPV are [[sexually transmitted diseases]] endemic among [[promiscuous]] people, with 80% of those who have sex outside of marriage suffering from the disease.<ref>http://www.hopkinsmedicine.org/hnf/hnf_6403.htm</ref> These strains of HPV have been associated with 70% of cervical cancer cases and may also play a role in the development of other types of cancer <ref>[http://www.cancer.gov/cancertopics/factsheet/Risk/HPV]</ref>. In June 2006, the U.S. Food and Drug Administration approved the first HPV vaccine without reviewing any epidemiological studies and merely monitoring for a brief period elevated [[antibody]] levels in recipients of the vaccine.<ref> http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5602a1.htm</ref>